Vahid Ghanbarinejad

744 total citations
18 papers, 554 citations indexed

About

Vahid Ghanbarinejad is a scholar working on Epidemiology, Physiology and Oncology. According to data from OpenAlex, Vahid Ghanbarinejad has authored 18 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 6 papers in Physiology and 5 papers in Oncology. Recurrent topics in Vahid Ghanbarinejad's work include Biochemical effects in animals (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Aldose Reductase and Taurine (5 papers). Vahid Ghanbarinejad is often cited by papers focused on Biochemical effects in animals (6 papers), Liver Disease Diagnosis and Treatment (6 papers) and Aldose Reductase and Taurine (5 papers). Vahid Ghanbarinejad collaborates with scholars based in Iran, China and United States. Vahid Ghanbarinejad's co-authors include Reza Heidari, Mohammad Mehdi Ommati, Hossein Niknahad, Akram Jamshidzadeh, Negar Azarpira, Narges Abdoli, Hamidreza Mohammadi, Asrin Ahmadi, Omid Farshad and Asma Najibi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomedicine & Pharmacotherapy and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

Vahid Ghanbarinejad

18 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vahid Ghanbarinejad Iran 14 134 128 113 105 102 18 554
Hamidreza Mohammadi Iran 16 93 0.7× 103 0.8× 114 1.0× 113 1.1× 96 0.9× 35 655
Khadijeh Mousavi Iran 14 75 0.6× 78 0.6× 85 0.8× 93 0.9× 56 0.5× 20 409
Arastoo Saeedi Iran 11 85 0.6× 78 0.6× 61 0.5× 88 0.8× 59 0.6× 16 456
Asrin Ahmadi Iran 9 62 0.5× 54 0.4× 82 0.7× 79 0.8× 77 0.8× 10 405
Vijay R. More United States 14 122 0.9× 35 0.3× 53 0.5× 84 0.8× 233 2.3× 19 740
Beatrice Arezzini Italy 14 90 0.7× 38 0.3× 96 0.8× 55 0.5× 138 1.4× 20 725
Heather B. Clair United States 13 358 2.7× 74 0.6× 58 0.5× 92 0.9× 381 3.7× 14 1.1k
Luděk Šišpera Czechia 14 216 1.6× 211 1.6× 50 0.4× 42 0.4× 70 0.7× 31 565
Susan E. Donohue United States 17 60 0.4× 104 0.8× 126 1.1× 51 0.5× 60 0.6× 26 850
Junji Kuroda Japan 15 77 0.6× 22 0.2× 66 0.6× 65 0.6× 190 1.9× 39 718

Countries citing papers authored by Vahid Ghanbarinejad

Since Specialization
Citations

This map shows the geographic impact of Vahid Ghanbarinejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vahid Ghanbarinejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vahid Ghanbarinejad more than expected).

Fields of papers citing papers by Vahid Ghanbarinejad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vahid Ghanbarinejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vahid Ghanbarinejad. The network helps show where Vahid Ghanbarinejad may publish in the future.

Co-authorship network of co-authors of Vahid Ghanbarinejad

This figure shows the co-authorship network connecting the top 25 collaborators of Vahid Ghanbarinejad. A scholar is included among the top collaborators of Vahid Ghanbarinejad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vahid Ghanbarinejad. Vahid Ghanbarinejad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ghanbarinejad, Vahid, Akram Jamshidzadeh, Omid Farshad, et al.. (2021). Apoptosis-inducing factor plays a role in the pathogenesis of hepatic and renal injury during cholestasis. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(6). 1191–1203. 24 indexed citations
2.
Firouzabadi, Negar, et al.. (2021). Impact of ACE2 genetic variant on antidepressant efficacy of SSRIs. Acta Neuropsychiatrica. 34(1). 30–36. 14 indexed citations
3.
Ghanbarinejad, Vahid, et al.. (2021). Disturbed mitochondrial redox state and tissue energy charge in cholestasis. Journal of Biochemical and Molecular Toxicology. 35(9). e22846–e22846. 11 indexed citations
4.
Abdoli, Narges, Vahid Ghanbarinejad, Hamidreza Mohammadi, et al.. (2019). The potential role of mitochondrial impairment in the pathogenesis of imatinib-induced renal injury. Heliyon. 5(6). e01996–e01996. 23 indexed citations
5.
Ommati, Mohammad Mehdi, et al.. (2019). The neuroprotective properties of carnosine in a mouse model of manganism is mediated via mitochondria regulating and antioxidative mechanisms. Nutritional Neuroscience. 23(9). 731–743. 38 indexed citations
6.
Ghanbarinejad, Vahid, Asrin Ahmadi, Hossein Niknahad, Mohammad Mehdi Ommati, & Reza Heidari. (2019). Carnosine Mitigates Manganese Mitotoxicity in an In Vitro Model of Isolated Brain Mitochondria. Advanced Pharmaceutical Bulletin. 9(2). 294–301. 10 indexed citations
7.
8.
9.
Heidari, Reza, Hamidreza Mohammadi, Vahid Ghanbarinejad, et al.. (2018). Proline supplementation mitigates the early stage of liver injury in bile duct ligated rats. Journal of Basic and Clinical Physiology and Pharmacology. 30(1). 91–101. 33 indexed citations
10.
Heidari, Reza, Vahid Ghanbarinejad, Mohammad Mehdi Ommati, Akram Jamshidzadeh, & Hossein Niknahad. (2018). Regulation of mitochondrial function and energy metabolism: A primary mechanism of cytoprotection provided by carnosine. SHILAP Revista de lepidopterología. 11 indexed citations
11.
Ommati, Mohammad Mehdi, Reza Heidari, Vahid Ghanbarinejad, Narges Abdoli, & Hossein Niknahad. (2018). Taurine Treatment Provides Neuroprotection in a Mouse Model of Manganism. Biological Trace Element Research. 190(2). 384–395. 48 indexed citations
12.
Heidari, Reza, Vahid Ghanbarinejad, Hamidreza Mohammadi, et al.. (2018). Dithiothreitol supplementation mitigates hepatic and renal injury in bile duct ligated mice: Potential application in the treatment of cholestasis-associated complications. Biomedicine & Pharmacotherapy. 99. 1022–1032. 39 indexed citations
13.
Heidari, Reza, Vahid Ghanbarinejad, Mohammad Mehdi Ommati, et al.. (2018). Mitochondrial dysfunction as a mechanism involved in the pathogenesis of cirrhosis-associated cholemic nephropathy. Biomedicine & Pharmacotherapy. 109. 271–280. 39 indexed citations
14.
Heidari, Reza, Akram Jamshidzadeh, Vahid Ghanbarinejad, Mohammad Mehdi Ommati, & Hossein Niknahad. (2018). Taurine supplementation abates cirrhosis-associated locomotor dysfunction. Clinical and Experimental Hepatology. 4(2). 72–82. 33 indexed citations
15.
Heidari, Reza, Hossein Niknahad, Hamidreza Mohammadi, et al.. (2018). Betaine treatment protects liver through regulating mitochondrial function and counteracting oxidative stress in acute and chronic animal models of hepatic injury. Biomedicine & Pharmacotherapy. 103. 75–86. 91 indexed citations
16.
Heidari, Reza, Vahid Ghanbarinejad, Mohammad Mehdi Ommati, Akram Jamshidzadeh, & Hossein Niknahad. (2018). Mitochondria protecting amino acids: Application against a wide range of mitochondria-linked complications. PharmaNutrition. 6(4). 180–190. 26 indexed citations
17.
Ahmadi, Nahid, Vahid Ghanbarinejad, Mohammad Mehdi Ommati, Akram Jamshidzadeh, & Reza Heidari. (2018). Taurine prevents mitochondrial membrane permeabilization and swelling upon interaction with manganese: Implication in the treatment of cirrhosis‐associated central nervous system complications. Journal of Biochemical and Molecular Toxicology. 32(11). e22216–e22216. 35 indexed citations
18.
Heidari, Reza, Vahid Ghanbarinejad, Hamidreza Mohammadi, et al.. (2017). Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice. Biomedicine & Pharmacotherapy. 97. 1086–1095. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamidreza Mohammadi Breakdown of academic impact, for papers by Khadijeh Mousavi Breakdown of academic impact, for papers by Arastoo Saeedi Breakdown of academic impact, for papers by Asrin Ahmadi Breakdown of academic impact, for papers by Vijay R. More Breakdown of academic impact, for papers by Beatrice Arezzini Breakdown of academic impact, for papers by Heather B. Clair Breakdown of academic impact, for papers by Luděk Šišpera Breakdown of academic impact, for papers by Susan E. Donohue Breakdown of academic impact, for papers by Junji Kuroda
Rankless by CCL
2026